Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-17-003024
Filing Date
2017-11-14
Accepted
2017-11-14 16:07:02
Documents
54
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT sonoma_10q-093017.htm 10-Q 375462
2 CERTIFICATION sonoma_10q-ex3101.htm EX-31.1 8550
3 CERTIFICATION sonoma_10q-ex3102.htm EX-31.2 8233
4 CERTIFICATION sonoma_10q-ex3201.htm EX-32.1 4206
  Complete submission text file 0001683168-17-003024.txt   2386606

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE snoa-20170930.xml EX-101.INS 414901
6 XBRL SCHEMA FILE snoa-20170930.xsd EX-101.SCH 28750
7 XBRL CALCULATION FILE snoa-20170930_cal.xml EX-101.CAL 50583
8 XBRL DEFINITION FILE snoa-20170930_def.xml EX-101.DEF 69348
9 XBRL LABEL FILE snoa-20170930_lab.xml EX-101.LAB 217554
10 XBRL PRESENTATION FILE snoa-20170930_pre.xml EX-101.PRE 170313
Mailing Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954
Business Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954 707-283-0550
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-33216 | Film No.: 171201484
SIC: 2834 Pharmaceutical Preparations